About ZeClinics
ZeClinics is a Healthcare company based in Barcelona (Spain) founded in 2013. Zebrafish models for toxicity studies are developed by ZeClinics CRO. Its website zeclinics.com draws about 22 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified.
Company details
ZeClinics was founded in 2013 and is based in Barcelona, Spain, where support from University Pompeu Fabra and incubation at Barcelona Biomedicine Research Park are provided. Operations focus on contract research organization services in the biotech sector, including toxicity, efficacy, and genesis assays conducted on zebrafish with CRISPRCas9 technology. Proprietary models developed by the company have been licensed to institutions such as Harvard, MIT, and the Broad Institute.
- Headquarters Barcelona, Spain
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website zeclinics.com
- Social LinkedIn X Facebook YouTube
- Latest Funding Round$108.22K (USD), Grant
Oct 2022
- InvestorsEuropean Union
& 1 more
Apps and channels of ZeClinics
its YouTube channel ZeClinics SL has 51 subscribers and 12 videos.
Videos from ZeClinics
The most watched videos on ZeClinics's YouTube channel, ZeClinics SL (51 subscribers). Click a video to play it here.
More on ZeClinics SL.
Funding Insights of ZeClinics
- Total Rounds 7
- Last Round Grant — $108,225
- First Round $28,420
(Jan 2017)
- Investors Count 2
All 7 funding rounds of ZeClinics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $108,225 | Grant | – | – | |
| Jan 2020 | $501,992 | Grant | – | – | |
| Oct 2019 | $274,352 | Grant | – | – | |
| Jun 2019 | $180,220 | Grant | – | – | |
| Mar 2019 | $2.09M | Grant | – | – | |
| Apr 2017 | $1.99M | Grant | – | – | |
| Jan 2017 | $28,420 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in ZeClinics
ZeClinics has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government agency and accelerator focusing on innovative startups and SMEs | eicfund.eu | Brussels, Belgium | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for ZeClinics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ZeClinics
3 dated milestones of ZeClinics across 9 years, from founding to its latest funding, stage changes and deals.
- Founded ZeClinics is founded.
- Funding First funding round of $28K.
- Funding Latest funding round, Grant, of $108K.
Web traffic of ZeClinics
The website of ZeClinics (zeclinics.com) receives about 21.8K visits a month.
- Monthly visits21.8K
▲ 13.8% vs previous month
Websites whose visitors overlap most with ZeClinics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| facebook.com | 100% | 12.1B | #3 | View details | |
| invivobiosystems.com | 79% | 8.4K | #2,614,697 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zeclinics
Complete news archive for ZeClinics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZeClinics
ZeClinics was founded in 2013 and raised its 1st funding round 4 years after it was founded.
ZeClinics is headquartered in Barcelona, Spain. It is registered at Barcelona, Catalonia, Spain.
ZeClinics was founded in 2013 and is based in Barcelona, Spain, where support from University Pompeu Fabra and incubation at Barcelona Biomedicine Research Park are provided. Operations focus on contract research organization services in the biotech sector, including toxicity, efficacy, and genesis assays conducted on zebrafish with CRISPRCas9 technology. Proprietary models developed by the company have been licensed to institutions such as Harvard, MIT, and the Broad Institute.
ZeClinics has 2 investors. Key investors include European Union, and EIC Fund.